Promoting Access to Medical Technologies and Innovation, Anthony Taubman, Director, Intellectual Property Division World Trade Organization (WTO), Geneva

Exceptions and Limitations to Patent Rights; Patent-related. Flexibilities under TRIPS and Doha Declaration, Catherine Margellou, Director, Legal Support, Hellenic Industrial Property Organisation (OBI), Athens

Research and Innovation in Drug Discovery and Diagnostics.Challenges and Problem, Alexander Pintzas, Director, Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, Athens

Commercializing research into patentable Inventions; Intellectual Property Strategy, Konstantinos Frouzis, President of the Hellenic Association of Pharmaceutical Companies (SFEE), Athens

Open Innovation Collaboration in Pharmaceutical Research, Mr. Andrew-Stephen Brown, Head, Intellectual Property Department, Pharmathen Pharmaceuticals, Athens

The EU Public Health Policy Ensuring Access to Medicines, Sib Hayer, Policy Advisor, Intellectual Property & Public Procurement Unit, DG Trade, European Commission, Brussels

New Business Models in Financing Innovation; Public-Private Partnerships; WIPO Re:Search,
Mr. Thomas Bombelles, Head, Global Health, WIPO

Competition Policy; Enforcement Issues, Paul Csiszar, Director of Basic Industries, Manufacturing and Agriculture, DG Competition, European Commission, Brussels

Closing Remarks, C. Polyzogopoulos, President of the AC, OBI